Glycated Albumin better indicator than A1C
Glycemic control in patients with diabetes and nephropathy-- GA better indicator than A1C
Studies show that the Glycated Albumin (GA) assay more accurately reflects recent glycemic control in patients on dialysis relative to A1C.
Reduced A1C levels tend to give patients and their caregivers a false sense of security, suggesting that blood sugars are lower than they really are.
Reports reveal that the GA assay, measuring glycation of albumin (not hemoglobin), is more accurate in patients with advanced nephropathy and better predicts survival and hospitalizations.
